María José Juan: Biochemical relapse in prostate cancer
María José Juan posted on X about recent paper by Akihiro Matsukawa et al., titled “Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis” published on Prostate Cancer.
Authors: Akihiro Matsukawa, Takafumi Yanagisawa, Tamas Fazekas, Marcin Miszczyk, Ichiro Tsuboi, Mehdi Kardoust Parizi, Ekaterina Laukhtina, Jakob Klemm, Stefano Mancon, Keiichiro Mori, Shoji Kimura, Jun Miki, Juan Gomez Rivas, Timo F. W. Soeterik, Thomas Zilli, Derya Tilki, Steven Joniau, Takahiro Kimura, Shahrokh F. Shariat, Pawel Rajwa
“Biochemical relapse in prostate cancer…do we irradiate with 0.2 mg/mL or ask for PETPSMA to look for oligometastatic disease? What are the best therapeutic options? A systematic review, meta-analysis and network meta-analysis.”
Source: María José Juan/X
María José Juan Fita is an Attending Physician and Medical Oncologist at the Valencian Institute of Oncology Foundation. Her research focuses on clinical and translational studies in urothelial, renal, and prostate cancers, particularly on genitourinary tumors and the development of new anticancer drugs. Dr. Juan Fita is a member of ESMO and the Spanish Society of Medical Oncology (SEOM).
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023